Not All Missed Doses Are the Same: Sustained NNRTI Treatment Interruptions Predict HIV Rebound at Low-to-Moderate Adherence Levels

• Jean-Jacques Parienti ,

  * E-mail: parienti-jj@chu-caen.fr

  Affiliations Clinical Research and Biostatistics, and Infectious Diseases Departments, Côte de Nacre University Hospital, Caen, France, Pierre et Marie Curie University Paris 6, UMR S707 and INSERM U707, Paris, France

  ⨯
• Moupali Das-Douglas,

  Affiliation Epidemiology and Prevention Interventions Center, Division of Infectious Diseases, and The Positive Health Program, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Véronique Massari,

  Affiliation Pierre et Marie Curie University Paris 6, UMR S707 and INSERM U707, Paris, France

  ⨯
• David Guzman,

  Affiliation Epidemiology and Prevention Interventions Center, Division of Infectious Diseases, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Steven G. Deeks,

  Affiliation Epidemiology and Prevention Interventions Center, Division of Infectious Diseases, and The Positive Health Program, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Renaud Verdon,

  Affiliation Clinical Research and Biostatistics, and Infectious Diseases Departments, Côte de Nacre University Hospital, Caen, France

  ⨯
• David R. Bangsberg

  Affiliation Partners AIDS Research Center, Massachusetts General Hospital, Harvard University, Boston, Massachusetts, United States of America

  ⨯